Where is Biogen Inc located?
Cambridge, Massachusetts
Biogen Idec Inc. Cambridge, Massachusetts, U.S. Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
How do I contact Biogen?
You can reach a Biogen Support Coordinator Monday through Friday from 8:30 AM until 8 PM ET, or you can reach a Nurse Educator 24/7 at 1-800-456-2255.
Is Biogen a pharma company?
Unlike the products of many pharmaceutical companies, Biogen’s drugs are not mass-marketed on prime-time television. Biogen is a biotechnology company that makes only a handful of advanced drugs to treat patients with neurological diseases.
Is Biogen a Swiss company?
The international corporate headquarters of Biogen are in Zug, Switzerland. Our branches in more than 30 countries and network of distribution partners spanning more than 50 additional countries enable us to offer our therapies to patients around the world.
Is aducanumab available?
While the drug has been approved by the FDA, it is not yet available to patients. The timeline for the drug to be made available by the drug company is not yet clear. It could be several months. Will patients be able to get aducanumab at the Alzheimer’s Disease Research Center (ADRC)?
What happened to IDEC Pharmaceuticals?
The pharmaceutical company merger spree has produced corporate names like GlaxoSmithKline and AstraZeneca. Now the biotechnology industry is getting its own combination nameplate — Biogen Idec.
Who is the CEO of Biogen?
Michel Vounatsos (Jan 6, 2017–)
Biogen/CEO
Biogen CEO Michel Vounatsos joins CNBC’s Meg Tirrell on ‘Power Lunch’ to discuss the FDA’s decision to approve the company’s Alzheimer’s drug.
Who founded Biogen?
Charles Weissmann
Kenneth MurrayPhillip Allen SharpWalter Gilbert
Biogen/Founders
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological …
Who is the owner of Biogen?
CEO Michel Vounatsos
Is Aduhelm a pill?
What is Aduhelm? Aduhelm is a brand-name prescription medication that’s used to treat Alzheimer’s disease. It’s FDA-approved for adults with early stages of the disease who have mild cognitive impairment or mild dementia.
Is aducanumab a cure?
Is aducanumab a cure for Alzheimer’s and all other dementia? No. Aducanumab is the first drug to address the underlying biology of the disease. According to the FDA, aducanumab reduces amyloid plaques, which is reasonably likely to lead to a reduction in clinical decline due to Alzheimer’s disease.
Is Biogen owned by Roche?
& SOUTH SAN FRANCISCO–(BUSINESS WIRE)–Biogen Idec (Nasdaq: BIIB) and Genentech, Inc. a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced that they have agreed to amend their collaboration on antibodies targeting CD20.
Where is Biogen Idec limited innovation house in Maidenhead?
Biogen Idec Limited Innovation House 70 Norden Road Maidenhead Berkshire SL6 4AY United Kingdom. Phone: +44 1628 501 000 Fax: +44 1628 501 010 [email protected]. Directions
Where is the corporate headquarters of Biogen Inc?
Contact Biogen CORPORATE HEADQUARTERS. Biogen Inc. 225 Binney Street Cambridge, MA 02142 USA. Biogen Corporate Contacts. INTERNATIONAL HEADQUARTERS
How to contact Biogen for product support?
This product support information is applicable to patients who have been prescribed Biogen therapies in the United States only. For product support in countries outside of the U.S., please contact the Biogen affiliate in your country or email [email protected] if your country is not represented.
What is the mission of Biogen Idec?
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. We believe that no other disease area holds as much need or as much promise for medical breakthroughs as…